Phenyx v2.5 is now available – try it today!

IonSource Daily Links to 
Mass Spectrometry, Biotechnology and Pharmaceutical  Industry News

 

IonSource Home | Disclaimer

Note: News stories may be minutes or several days old and should not be used for investment purposes.

-

-

-
   
07/01/08 Thermo Fisher Scientific Acquires Open Biosystems, Creating Unmatched RNAi Platform
   
06/30/08 Myriad Genetics Reports Results of U.S. Phase 3 Trial of Flurizan™ in Alzheimer's Disease
   
06/26/08 European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment 
   
  Bristol-Myers Squibb Completes Acquisition of Kosan Biosciences Incorporated
   
06/18/08 Cervarix™, GSK’s cervical cancer vaccine, wins tender for UK national immunisation programme
   
  Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Kosan Biosciences Incorporated
   
06/17/08 Novartis:Rasilez® ASPIRE HIGHER clinical program expands to 35,000 patients in 14 trials, the largest cardio-renal outcomes program ever
   
06/16/08 Lilly: FDA Approves Cymbalta® for the Management of Fibromyalgia
   
 

Thermo Fisher Scientific Launches Comprehensive Online Metabolomics Resource Center

   
06/13/08 Novartis: Higher initial dose of Glivec achieved better early responses than standard dose for patients with chronic myeloid leukemia
   
  Roche: New data reveals Actemra is the first and only biologic drug to show superiority over current standard of care in rheumatoid arthritis 
   
  GSK: US FDA approves Requip® XL™, the first and only oral once-daily non-ergot dopamine agonist for Parkinson’s disease
   
  Data Show that Abbott's HUMIRA® (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
   
06/12/08 Geron Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System
   
  Invitrogen and Applied Biosystems to Combine
   
06/11/08 Myriad Genetics' Alzheimer's Disease Drug Mechanism of Action Detailed in Nature Article
   
  Genentech Settles Dispute Related To Cabilly Patent
   
06/10/08 Roche moves investigational diabetes drug, Taspoglutide, into Phase III clinical trials 
   
06/4/08 MDS: Scientific Collaboration Seeks to Develop New Methods to Better Identify Contaminants in Drinking Water
   
06/2/08 Thermo Fisher Scientific Strengthens Presence in India with Acquisition of Chemito Technologies
   
  Agilent Technologies Introduces Triple Quadrupole GC/MS, Updated Triple Quadrupole LC/MS at American Society for Mass Spectrometry
   
  Nonlinear dynamics to distribute GeneBio’s Phenyx worldwide
   
05/31/08 Roche: Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer 
   
05/30/08 Roche: Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer 
   
   
05/29/08 Geneva Bioinformatics (GeneBio) SA and Protagen AG today announced a distribution agreement that allows GeneBio to distribute Protagen’s Modiro, a novel software tool enabling rapid and automated detection of true post-translational modifications in MS/MS datasets.
   
  Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems, Software and Workflow Solutions at ASMS 2008
   
05/28/08 GeneBio Announces New Addition to its MS Platform Solutions - SmileMS : SmileMS is a unique software platform for the identification and analysis of small molecules by mass spectrometry.
   
  Novartis: Extavia® approved in European Union for treatment of multiple sclerosis, first in planned portfolio of therapies from Novartis
   
05/20/08 Biotech could run into a rough patch, link to article at The San Francisco Chronicle
   
05/19/08 Profits elusive, but biotech still lures investors, link to article at The San Francisco Chronicle
   
  GSK: First pre-pandemic vaccine approved to help protect against pandemic influenza
   
05/16/08 Thermo Fisher Scientific Names Marc N. Casper as Chief Operating Officer
   
  Millenium: New Data Support High Complete Remission Rates With VELCADE® (Bortezomib) For Injection Based Therapies In Patients With Newly Diagnosed Multiple Myeloma
   
05/15/08 GE Healthcare to Distribute GeneBio’s Phenyx in Latin America
   
05/14/08 Takeda Completes Acquisition of Millennium
   
05/09/08 Roche: Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis 
   
  Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
   
  Applera Corporation's Board of Directors Formally Approves Proposed Separation of Its Celera Business
   
05/06/08
   
  Geron: University of Edinburgh Human Embryonic Stem Cell Program Awarded UK Grant Funding
   
04/29/08 Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of RITUXAN in Systemic Lupus Erythematosus
   
  Compugen Announces Discovery of Blood Based Biomarker for Diagnosis of Lung Cancer
   
  Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
   
04/28/08 Breakthrough technique pioneered at Novartis research institute restores light sensitivity in damaged retinas
   
04/25/08 Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
   
  GSK receives positive opinion for conditional approval of new oral breast cancer treatment, Tyverb (lapatinib)
   
04/24/08 High court slashes $200 million from Genetech judgment
   
  Amgen first-quarter profit is nearly flat on declining sales
   
  BMS: Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company
   
  Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance
   
04/23/08 Novartis announces 20% average reduction in price of malaria drug Coartem® to further accelerate access in malaria-endemic regions
   
04/21/08 Novartis reports higher sales and earnings in first quarter of 2008 showing healthcare portfolio well on the way to new growth cycle
   
04/20/08 Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer
   
04/17/08 Bristol-Myers Squibb to Announce Results for the First Quarter of 2008 on April 24
   
04/17/08 Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
   
  Abbott Announces HUMIRA® (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
   
04/15/08 Roche fully acquires privately-owned biotech company Piramed 
   
04/14/08 Genentech and Biogen Idec Announce Top-Line Results From a Phase II/III Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis
   
04/11/08 Novartis ASA404, a novel cancer agent, begins pivotal trial to explore new approach in treating lung cancer, the leading cause of cancer death
   
  Lilly: ALIMTA® (pemetrexed for injection) Receives European Approval for Histologically-Based Use in First-Line Treatment of Most Common Lung Cancer
   
  Vermillion Announces Issuance of U.S. Patent Covering the Discovery of Novel Forms of Brain Natriuretic Peptide
   
04/10/08 Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
   
04/08/08 Novartis: ACZ885, a new biological drug in development, shows potential in treating serious life-long autoinflammatory diseases
   
04/07/08 Thermo Fisher Scientific Introduces New Catalog for China
   
  Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon
   
04/04/08 GSK: FDA approves Rotarix [Rotavirus Vaccine, live, oral], the first vaccine licensed to complete the rotavirus immunisation series by four months of age
   
04/03/08 Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
   
  Medarex Announces Ipilimumab Program Continues to Move Forward 
   
04/02/08 Amgen: Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
   
03/24/08 BMS: BARACLUDE® (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
- Data Indicate Pre-existing Lamivudine Resistance Predisposes Patients to Higher Rates of BARACLUDE Resistance
   
  Biogen Idec: Researchers Report Neublastin Virtually Restores Complete Long-Term Sensory Motor Function in Preclinical Studies
   
03/20/08 Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
   
03/19/08 Merck: Supplemental Application for GARDASIL®, Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45
   
03/17/08 Millennium Expands IBD Franchise with Addition of New Development Candidate
   
  Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
   
03/13/08 Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
   
03/11/08 Geron:U.S. Patent Office Upholds Two Additional Human Embryonic Stem Cell Patents in Reexamination Decisions
   
03/10/08 Novartis: Femara® helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
   
03/07/08 Lilly Announces Termination of AIR Insulin Program
   
03/06/08  Thermo Fisher Scientific Extends LTQ Orbitrap Mass Spectrometry Performance in Proteomics with ETD and MALDI Capabilities
   
  Merck's ISENTRESS® (raltegravir) Tablets in Combination with other Anti-HIV Medicines Maintained Reductions in HIV-1 Viral Load and Increased CD4 Cell Counts Through 48 Weeks of Therapy in Treatment-Experienced Adults
   
03/03/08 Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008
   
  GSK: FDA grants Priority Review For Promacta / Revolade (Eltrombopag), eltrombopag would be the first oral thrombopoeitin (TPO) receptor agonist 
   
02/29/08 Roche: Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer
   
  Update on GSK's malaria treatments: Dacart and Lapdap
   
02/28/08 Novartis: Everolimus (RAD001) significantly extends progression-free survival in advanced kidney cancer patients after failure of other targeted therapy
   
02/23/08 FDA approves Avastin to treat breast cancer , link to article at The San Francisco Chronicle 
   
  Roche: FDA grants accelerated approval of Avastin in combination with paclitaxel chemotherapy for first-line treatment of patients with advanced HER2-negative breast cancer 
   
02/18/08 Thermo Scientific LTQ Orbitrap™ Mass Spectrometer Selected for Ground-Breaking Research in Disease Treatment and Prevention
   
02/08/08 GeneBio Announced the Release of  Version 7.0 of the Renowned Melanie 2-D Gel Analysis Platform.
   
02/06/08 Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
   
  GSK: GlaxoSmithKline responds to findings in ACCORD study
   
  Lilly: FDA Advisory Committee Supports Efficacy and Safety of Zyprexa® Long-Acting Injection (LAI) for Schizophrenia Treatment
   
  BMS: CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ® (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
Data also showed differences in gastrointestinal and lipid effects between REYATAZ/ritonavir and lopinavir/ritonavir among study population
   
  Amgen: Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
   
  Applied Biosystems Expands Line of Labeling Chemistry Reagents to Help Improve Proteomics Research
   
02/05/08 Geron’s Second U.S. Patent for Production of Pancreatic Islets From Human Embryonic Stem Cells Strengthens Company’s Intellectual Property Position
   
02/01/08 Novartis: Galvus®, a new treatment for patients with type 2 diabetes, receives European approval for label update paving the way for EU launches
   
  Amgen: New Findings Show Enbrel(R) (etanercept) Significantly Reduced Levels of C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate to Severe Plaque Psoriasis
   
01/31/08